These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33848919)

  • 21. NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity.
    Amin S; Aktar S; Rahman MM; Chowdhury MMH
    Microbes Infect; 2022 Feb; 24(1):104913. PubMed ID: 34838941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway.
    Arioz BI; Tastan B; Tarakcioglu E; Tufekci KU; Olcum M; Ersoy N; Bagriyanik A; Genc K; Genc S
    Front Immunol; 2019; 10():1511. PubMed ID: 31327964
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NLRP3 inflammasome: A joint, potential therapeutic target in management of COVID-19 and fertility problems.
    Bazrafkan M; Hosseini E; Nazari M; Amorim CA; Sadeghi MR
    J Reprod Immunol; 2021 Nov; 148():103427. PubMed ID: 34563758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NLRP3 inflammasome activation and SARS-CoV-2-mediated hyperinflammation, cytokine storm and neurological syndromes.
    Dutta D; Liu J; Xiong H
    Int J Physiol Pathophysiol Pharmacol; 2022; 14(3):138-160. PubMed ID: 35891930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe COVID-19: NLRP3 Inflammasome Dysregulated.
    van den Berg DF; Te Velde AA
    Front Immunol; 2020; 11():1580. PubMed ID: 32670297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leptin Aggravates Periodontitis by Promoting M1 Polarization via NLRP3.
    Han Y; Huang Y; Gao P; Yang Q; Jia L; Zheng Y; Li W
    J Dent Res; 2022 Jun; 101(6):675-685. PubMed ID: 35050801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NLRP3 Inflammasome Modulation by Melatonin Supplementation in Chronic Pristane-Induced Lupus Nephritis.
    Bonomini F; Dos Santos M; Veronese FV; Rezzani R
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Putative Therapeutic Impact of Inflammasome Inhibitors against COVID-19-Induced ARDS.
    Nabavi SF; Sahebnasagh A; Shahbazi A; Nabavi SM; Azimi S; Kashani MK; Habtemariam S; Rahmani M; Badiee M; Hashemi J; Saghafi F; Amini K; Azimi M; Rezabakhsh A
    Curr Med Chem; 2023; 30(12):1406-1419. PubMed ID: 36065926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of the "segment" of spinal cord injury on the activity of the nucleotide-binding domain-like receptor protein 3 inflammasome and response to hormonal therapy.
    Majidpoor J; Mortezaee K; Khezri Z; Fathi F; Zali A; Derakhshan HB; Bariki MG; Joghataie MT; Shirazi R; Moradi F
    Cell Biochem Funct; 2021 Mar; 39(2):267-276. PubMed ID: 32893892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivary Levels of NLRP3 Inflammasome-Related Proteins as Potential Biomarkers of Periodontal Clinical Status.
    Isaza-Guzmán DM; Medina-Piedrahíta VM; Gutiérrez-Henao C; Tobón-Arroyave SI
    J Periodontol; 2017 Dec; 88(12):1329-1338. PubMed ID: 28691886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of inflammasome NLRP3 in the pathophysiology of viral infections: A focus on SARS-CoV-2 infection].
    Chemarin M; Dufies O; Mazet A; Mellan E; Coudereau R; Py BF; Boyer L; Venet F
    Med Sci (Paris); 2022; 38(6-7):545-552. PubMed ID: 35766852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role and mechanism of the nod-like receptor family pyrin domain-containing 3 inflammasome in oral disease.
    Lv K; Wang G; Shen C; Zhang X; Yao H
    Arch Oral Biol; 2019 Jan; 97():1-11. PubMed ID: 30315987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Melatonin attenuates prostatic inflammation and pelvic pain via Sirt1-dependent inhibition of the NLRP3 inflammasome in an EAP mouse model.
    Chen J; Zhang LG; Du HX; Zhan CS; Liu Y; Zhang M; Chen XG; Wen LP; Zhang L; Liang CZ
    Prostate; 2021 Nov; 81(15):1179-1190. PubMed ID: 34418127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal.
    Batiha GE; Al-Kuraishy HM; Al-Gareeb AI; Alruwaili M; AlRuwaili R; Albogami SM; Alorabi M; Saad HM; Simal-Gandara J
    Inflammopharmacology; 2023 Feb; 31(1):1-7. PubMed ID: 36418600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of inflammasome regulatory transcripts in periodontal disease.
    Aral K; Berdeli E; Cooper PR; Milward MR; Kapila Y; Karadede Ünal B; Aral CA; Berdeli A
    J Periodontol; 2020 May; 91(5):606-616. PubMed ID: 31557327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients.
    Gedefaw L; Ullah S; Leung PHM; Cai Y; Yip SP; Huang CL
    Cells; 2021 Apr; 10(4):. PubMed ID: 33923537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation.
    Chang YS; Ko BH; Ju JC; Chang HH; Huang SH; Lin CW
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury.
    Irrera N; Russo M; Pallio G; Bitto A; Mannino F; Minutoli L; Altavilla D; Squadrito F
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19.
    Saeedi-Boroujeni A; Mahmoudian-Sani MR; Nashibi R; Houshmandfar S; Tahmaseby Gandomkari S; Khodadadi A
    Immunopharmacol Immunotoxicol; 2021 Jun; 43(3):247-258. PubMed ID: 34015982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation.
    Bonaventura A; Vecchié A; Dagna L; Tangianu F; Abbate A; Dentali F
    Inflamm Res; 2022 Mar; 71(3):293-307. PubMed ID: 35113170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.